Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2004-10-12
pubmed:abstractText
Cardiac allograft vasculopathy (CAV), a disorder characterized by rapid development and progression of obliterative vasculopathy in the transplanted heart, continues to be a major cause of graft failure in long-surviving human transplants. The mechanisms and histopathologic processes of CAV remain unknown. Previous animal studies have shown that inhibition of matrix metalloproteinase (MMP) prevents migration and proliferation of smooth muscle cells in CAV. In this study, we hypothesized that MMPs may be expressed in and may play an important role in CAV.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1163-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15477110-Animals, pubmed-meshheading:15477110-Coronary Disease, pubmed-meshheading:15477110-Coronary Vessels, pubmed-meshheading:15477110-Heart Transplantation, pubmed-meshheading:15477110-Humans, pubmed-meshheading:15477110-Immunosuppressive Agents, pubmed-meshheading:15477110-Male, pubmed-meshheading:15477110-Matrix Metalloproteinase 2, pubmed-meshheading:15477110-Matrix Metalloproteinases, pubmed-meshheading:15477110-Phenyl Ethers, pubmed-meshheading:15477110-Postoperative Complications, pubmed-meshheading:15477110-Rats, pubmed-meshheading:15477110-Rats, Inbred F344, pubmed-meshheading:15477110-Rats, Inbred Strains, pubmed-meshheading:15477110-Tacrolimus, pubmed-meshheading:15477110-Tissue Inhibitor of Metalloproteinase-2, pubmed-meshheading:15477110-Transplantation, Homologous
pubmed:year
2004
pubmed:articleTitle
ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
pubmed:affiliation
Department of Thoracic and Cardiovascular Surgery, Juntendo University School of Medicine, Tokyo, Japan. ahariya@toranomon.gr.jp
pubmed:publicationType
Journal Article